CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.
Melese ES, Franks E, Cederberg RA, Harbourne BT, Shi R, Wadsworth BJ, Collier JL, Halvorsen EC, Johnson F, Luu J, Oh MH, Lam V, Krystal G, Hoover SB, Raffeld M, Simpson RM, Unni AM, Lam WL, Lam S, Abraham N, Bennewith KL, Lockwood WW.
Melese ES, et al. Among authors: harbourne bt.
Oncoimmunology. 2021 Dec 30;11(1):2010905. doi: 10.1080/2162402X.2021.2010905. eCollection 2022.
Oncoimmunology. 2021.
PMID: 35481284
Free PMC article.